Impact of menopausal status on risk of metastatic recurrence of breast cancer
Autor: | Marion Kuper-Hommel, Chunhuan Lao, Mark Elwood, Ross Lawrenson, Ian Campbell |
---|---|
Rok vydání: | 2021 |
Předmět: |
Oncology
medicine.medical_specialty Receptor ErbB-2 Proportional hazards model business.industry Hazard ratio Obstetrics and Gynecology Estrogen receptor Breast Neoplasms Disease medicine.disease Metastatic breast cancer Breast cancer Receptors Estrogen Internal medicine medicine Humans Female Cumulative incidence Menopause Neoplasm Recurrence Local Stage (cooking) Receptors Progesterone business |
Zdroj: | Menopause. 28:1085-1092 |
ISSN: | 1530-0374 |
DOI: | 10.1097/gme.0000000000001817 |
Popis: | Objective Menopausal status at diagnosis is an important factor for the management of breast cancer in younger women, and may affect the prognosis for these women. We aim to examine the association of menopausal status and risk of metastatic relapse for stage I-III breast cancer. Methods We included women diagnosed with stage I-III breast cancer at 45 to 55 years in the Auckland and Waikato Breast Cancer Registers. Cumulative incidence of metastatic relapse was examined by age group and by menopausal status after stratifying by estrogen receptor (ER) and progesterone receptor (PR) status. Cox proportional hazards model was used to estimate the adjusted hazard ratio of metastatic relapse by menopausal status after adjustment for age, ethnicity, year of diagnosis, socioeconomic status, public/private hospital treatment, mode of detection, cancer stage, grade and human epidermal growth factor receptor 2 status. Results We have identified 5,309 eligible women: 2,799 premenopausal, 929 perimenopausal, and 1,581 post-menopausal. There was significant difference in risk of metastatic recurrence between menopausal statuses for ER+ and/or PR+ cases, with a 10-year cumulative incidence of 11.2% for premenopausal, 12.4% for perimenopausal, and 15.6% for postmenopausal women. The adjusted hazard ratio of metastatic recurrence for postmenopausal compared to premenopausal women was 1.38 for ER+ and/or PR+ cases. Age did not affect the risk of metastatic relapse for ER+ and/or PR+ cases but affected the risk for ER- and PR- cases with a hazard ratio of 0.94 per year. Conclusions Women with earlier age at menopause, and ER+ and/or PR+ stage I-III breast cancer were more likely to develop metastatic breast cancer. Age increased the risk of metastatic relapse for women with ER- and PR- disease, but not for ER+ and/PR+ cancers. |
Databáze: | OpenAIRE |
Externí odkaz: |